81 studies found for:    "Acute erythroleukemia" "Acute erythroid leukemia"
Show Display Options
Rank Status Study
21 Completed Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclosporine;   Drug: melphalan;   Drug: methylprednisolone;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy
22 Completed Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: carboplatin;   Drug: fludarabine phosphate;   Drug: topotecan hydrochloride
23 Unknown  Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Condition: Leukemia
Interventions: Biological: recombinant interferon alfa;   Drug: amifostine trihydrate;   Drug: bromodeoxyuridine;   Drug: cytarabine;   Drug: idarubicin;   Drug: idoxuridine;   Drug: isotretinoin;   Drug: mitoxantrone hydrochloride
24 Unknown  Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: idarubicin;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
25 Completed Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Precancerous/Nonmalignant Condition;   Small Intestine Cancer
Interventions: Biological: anti-thymocyte globulin;   Biological: graft-versus-tumor induction therapy;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: peripheral blood stem cell transplantation
26 Completed Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Biological: filgrastim;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: tretinoin
27 Completed Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: methotrexate;   Procedure: allogeneic bone marrow transplantation;   Procedure: syngeneic bone marrow transplantation
28 Completed Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: etoposide;   Procedure: autologous bone marrow transplantation
29 Completed Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Drug: Cyclophosphamide;   Drug: Psoralen;   Drug: Thiotepa;   Procedure: Allogeneic bone marrow transplantation;   Procedure: In vitro-treated peripheral blood stem cell transplantation (PBSCT);   Radiation: Radiation Therapy (RT)
30 Unknown  Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
Condition: Leukemia
Interventions: Genetic: DNA analysis;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
31 Unknown  Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
Conditions: Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Biological: anti-thymocyte globulin;   Biological: donor lymphocytes;   Biological: filgrastim;   Biological: therapeutic allogeneic lymphocytes;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Other: pharmacological study;   Other: reduced-intensity transplant conditioning procedure;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
32 Completed Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: clofarabine;   Drug: cyclophosphamide
33 Recruiting Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous Condition;   Secondary Myelofibrosis
Interventions: Drug: Busulfan;   Drug: Cytarabine;   Drug: Fludarabine phosphate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
34 Active, not recruiting
Has Results
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: cytarabine;   Drug: methotrexate;   Other: laboratory biomarker analysis
35 Active, not recruiting Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: mitoxantrone hydrochloride
36 Unknown  Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Condition: Leukemia
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methotrexate;   Procedure: allogeneic hematopoietic stem cell transplantation
37 Unknown  Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Procedure: in vitro-treated bone marrow transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation
38 Completed Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: umbilical cord blood transplantation;   Drug: methylprednisolone
39 Completed Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Procedure: allogeneic bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Radiation: radiation therapy
40 Completed Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: irinotecan hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years